

What an mRNA melanoma vaccine may mean for cancer treatment
A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial. So, how does…

Scout bees are checking it out — divided opinions, the swarm hasn't committed.
- Platform
- 38%
- Community
- no read yet
- Value
- 90%
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
What people are saying
“AI-punched rith at the start? Thimb down! When the vaccine accessible for everyone?”
Similar episodes from other shows
More like Science Friday →
The extraordinary promise of personalised cancer vaccines

Cancer vaccines: Empowering the immune system

AI, Cancer Vaccines, and the Future of Personalized Medicine | Sid Sijbrandij on GitLab + Biotech

Inside Moderna’s Personalized Cancer Vaccine
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.


